Stage IVA Colorectal Cancer Active Not Recruiting Phase 2 Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0068496 (Stage IVA Colorectal Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02292758Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryTreatment